CYSTIC FIBROSIS

 

Changing the lives of Cystic Fibrosis Patients one breath at a time.

 

Dynamiks Health Care specializes in aggressive chest percussion therapy (CPT) for patients suffering from chronic respiratory ailments. Our goal is to slow down the progression of the disease by educating families and clinicians about a more effective way to achieve bronchial hygiene in the Cystic Fibrosis Patient.

 

We provide advance bronchial hygiene techniques that provide our patients with a better quality of life. Patients following our protocol show an increased PFT'S, weight gain, exercise endurance, and a REDUCTION in the need for hospitalizations. Frequent hospitalization increases patient's resistance to intravenous antibiotics and make them more susceptible to complications associated with infections.

 

Our patients are showing marked results when using aggressive therapy alone or in conjunction with the vest, flutter, Acapella and PEP mask.  This advanced technique is showing significant reduction in both the frequency and duration of hospital stays. This decrease is making a meaningful difference to the Cystic Fibrosis Patient in both longevity and their quality of life.

 

Cystic Fibrosis News

 

• Antibiotics being explored for the treatment of cystic fibrosis and muscular dystrophy have the potential to trigger autoimmune disease
  The code for every gene includes a message at the ...
   

• CF Foundation and CF care expert partnership yields striking progress for people with cystic fibrosis
  A decade of strategic efforts to improve care has ...
   

• Lung transplantation: A treatment option in end-stage lung disease
  In the past five years, the number of lung transpl...
   

• Lung-damaging molecule identified in higher concentrations in cystic fibrosis patients during symptom flare-ups
  A molecule previously linked to lung injuries in f...
   

• Success in mouse model of aniridia is first instance of drug reversing a congenital deformity
  University of British Columbia and Vancouver Coast...
   

• New technique for testing drugs to treat cystic fibrosis and epilepsy
  Researchers from the University of Southampton, in...
   

• FDA allows marketing of four "next generation" gene sequencing devices
  Today (November 19th, 2013) the U.S. Food and Drug...
   

• CF Foundation and CF care expert partnership yields striking progress for people with cystic fibrosis
  A decade of strategic efforts to improve care has ...
   

• Lung transplantation: A treatment option in end-stage lung disease
  In the past five years, the number of lung transpl...
   

• Lung-damaging molecule identified in higher concentrations in cystic fibrosis patients during symptom flare-ups
  A molecule previously linked to lung injuries in f...
   

• Success in mouse model of aniridia is first instance of drug reversing a congenital deformity
  University of British Columbia and Vancouver Coast...
   

• New technique for testing drugs to treat cystic fibrosis and epilepsy
  Researchers from the University of Southampton, in...
   

• FDA allows marketing of four "next generation" gene sequencing devices
  Today (November 19th, 2013) the U.S. Food and Drug...
   

• The thyroid gland and cystic fibrosis
  Research in the College of Veterinary Medicine at ...